Allervil

Quick links to important sections

Allervil

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allervil

Property Description
Active ingredient Pheniramine maleate
Form Tablets, Syrup, Injectable Solution, Eye drops
Pharmacological class H₁ Receptor Antagonist (First-Generation Antihistamine)
General purpose Relief of symptoms associated with allergic conditions
Origin Synthetic compound (Alkylamine derivative)

What Type of Medicine is Allervil?

Allervil is a pharmaceutical preparation whose primary active substance is Pheniramine maleate, classifying it as a first-generation antihistamine and a H1 receptor antagonist. This compound is a synthetic agent derived from the alkylamine chemical group, and its core function is to block the actions of histamine released during allergic responses. This drug classification is based on its pharmacological ability to modulate the body's reaction to external allergens. The chemical structure of Pheniramine allows it to influence the Central Nervous System, resulting in a characteristic sedative action that distinguishes it from newer, non-sedating antihistamines.


Allervil’s Composition and Available Forms

The active ingredient is specifically the salt form, Pheniramine maleate, and it is typically marketed as a single active ingredient product. Allervil is noted for its versatility in available dosage forms, which include common tablets and syrup for oral systemic administration. Crucially, it is also available as a potent injectable solution (ampoules) for specialized parenteral delivery and as localized eye drops intended for targeted topical application. This broad range confirms the drug's established utility in addressing both systemic and localized allergic needs.


What is the General Purpose of Pheniramine?

The general therapeutic purpose of Pheniramine is to mitigate the immediate, uncomfortable symptoms caused by the body's reaction to allergens. By performing H1 receptor antagonism, the medicine directly suppresses the effects of excess histamine on nerve endings and capillaries. This primary action has established clinical utility in managing various allergic manifestations and is essential for providing general relief from discomforts associated with hypersensitivity reactions. It specifically targets the suppression of intense pruritus (itching), the resolution of cutaneous swelling like urticaria (hives), and the reduction of excessive secretions linked to allergic rhinitis and conjunctivitis.

What side effects are possible with Allervil?

Possible Side Effects and Safety Information

The safety profile of Allervil is based on regulatory documentation identifying known adverse reactions and necessary precautions.

Adverse Reactions

The most frequently reported adverse reaction is somnolence (drowsiness) and other effects on the Central Nervous System (CNS). Other common adverse reactions reported across body systems include:

  • Nervous System Disorders: Dizziness, headache, fatigue, and coordination disturbance.
  • Gastrointestinal Disorders: Dry mouth, nausea, and epigastric distress.
  • Psychiatric Disorders: Anxiety and agitation.
  • Cardiac Disorders: Tachycardia.

Serious Adverse Reactions and Safety Restrictions

Serious adverse reactions reported in regulatory sources, though rare, include severe hypersensitivity reactions (e.g., anaphylactic shock) and blood dyscrasias (e.g., agranulocytosis). Use of the medicine is restricted or requires particular caution in the presence of certain conditions that may be aggravated by the drug's properties, such as:

  • Narrow-angle glaucoma.
  • Prostatic hypertrophy/urinary retention.
  • Stenosing peptic ulcer or pyloroduodenal obstruction.

Population-Specific Safety Considerations

The official safety information notes specific risks for certain patient groups. Neonates and premature infants are particularly susceptible to convulsions. Children may experience paradoxical excitation, a reaction opposite to the expected sedative effect. Elderly patients are generally more susceptible to the CNS side effects, such as sedation and dizziness, as well as anticholinergic effects like confusion and urinary retention.

Overdose

Overdosage is a recognized risk, and its manifestations can range from severe CNS depression (e.g., sedation, coma) to CNS stimulation (e.g., hyperpyrexia, convulsions), highlighting the need for vigilance regarding exposure.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Allervil (Pheniramine maleate) occurs when more than the normal amount is ingested. Due to the drug’s pharmacological profile, the regulatory-documented overdose manifestations involve a complex of Central Nervous System (CNS) effects. These range from profound sedation and drowsiness progressing to coma, to paradoxical CNS excitation with agitation, hallucinations, tremors, and convulsions (seizures).

System Documented Signs
Anticholinergic Dilated pupils, dry mouth, flushed skin, urinary retention, hyperthermia
Cardiopulmonary Tachycardia, cardiac arrhythmias (e.g., QRS widening), circulatory collapse, respiratory depression

When to Seek Immediate Medical Help Suspected overdose is classified as a severe event with potential life-threatening outcomes such as apnea, seizures, circulatory collapse, and cardiac arrest. For any suspected overdose, you must seek medical help right away. Contact the local emergency number or a Poison Control Center immediately for guidance on required actions.

Overdose Management and Risk: The official profile notes that no specific antidote is known for Pheniramine overdose. Treatment is strictly symptomatic and supportive, with a focus on continuous vital sign monitoring and intervention for severe symptoms. Overdose is officially documented as being typically more serious in children, who often present with dominant CNS stimulation rather than initial sedation, and elderly patients are at increased risk of both CNS and anticholinergic effects.

Therapeutic Uses of Allervil

Main Uses and Benefits of Allervil

Allervil is an antihistamine medication used to manage symptoms associated with various allergic conditions. It works by blocking the action of histamine, a natural substance in the body that triggers allergic reactions when the immune system responds to foreign particles like pollen, pet dander, or dust mites.

Treatment of Allergic Rhinitis

Allervil is primarily used to relieve symptoms of allergic rhinitis, commonly referred to as hay fever. These symptoms can occur seasonally or year-round and include:

  • Sneezing: Reducing the frequency and intensity of sneezing fits.
  • Rhinorrhea: Controlling a runny nose or excessive mucus production.
  • Nasal Congestion: Helping to alleviate the feeling of a blocked or stuffy nose.
  • Itching: Relieving itchiness in the nose, throat, or roof of the mouth.

Relief of Ocular Symptoms

In addition to nasal relief, Allervil is effective in treating allergic conjunctivitis. This condition affects the eyes and often accompanies respiratory allergies. The benefits include the reduction of:

  • Redness in the whites of the eyes.
  • Itchy or burning sensations in the eyes.
  • Excessive tearing or watery eyes.

Management of Skin-Related Allergies

Allervil is also used in the management of skin conditions triggered by allergic responses, such as chronic idiopathic urticaria (hives). Its application in these cases helps to:

  • Reduce Wheals: Decrease the number and size of raised, red bumps on the skin.
  • Alleviate Pruritus: Provide relief from the intense itching associated with hives.
  • Improve Skin Comfort: Lessen the overall skin irritation caused by chronic allergic reactions.

General Benefits for Daily Functioning

By controlling these physical symptoms, Allervil helps individuals maintain their daily routines with fewer interruptions. The medication is designed to provide long-acting relief, typically allowing for consistent symptom management throughout the day.

Regulatory References

  1. NIH National Center for Biotechnology Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Allervil (Pheniramine Maleate) — Official Regulatory Information

The regulatory profile for Allervil (Pheniramine maleate) defines eligibility based on age, specific medical conditions, and physiological status, as documented in official government sources.

Eligibility Scope Status / Rule Official Classification
Populations for whom use is allowed Adults and adolescents (typically 12 years and over) who do not have any specified restrictions. Labeled Use
Populations for whom use is contraindicated Patients with Hypersensitivity to pheniramine, Newborns/Premature Infants, and patients currently taking a Monoamine Oxidase Inhibitor (MAOI). Absolute Prohibition

Age-Related Eligibility Rules

Use is not recommended for children under six years of age. Older adults require special caution due to increased susceptibility to effects like sedation and confusion; some labels advise avoiding use in the elderly with confusion.

Condition-Specific Eligibility Rules

Use is contraindicated in conditions worsened by anticholinergic effects, including Narrow-Angle Glaucoma, Symptomatic Prostatic Hypertrophy, and diseases of the lower respiratory tract, such as acute asthma attacks. Patients with renal or hepatic impairment are required to use the medicine with caution.

Pregnancy and Lactation Eligibility

Use during breastfeeding is generally contraindicated or not recommended. Specific warnings advise against use during the third trimester of pregnancy.


Connection to the Overall Eligibility Profile

Official regulatory documents establish who can and cannot use the medicine by creating non-negotiable prohibitions for specific high-risk groups, such as newborns and patients on MAOIs. Beyond these absolute contraindications, eligibility is defined by conditional use requirements, which mandate caution in populations like older adults and those with pre-existing comorbidities affected by the drug's properties.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation for Allervil (Pheniramine maleate) identifies interaction constraints primarily driven by its effects on the central nervous system and its metabolic clearance. The interaction profile is defined by additive pharmacodynamic effects and formal regulatory prohibitions against co-administration with specific drug classes.

Interaction Scope Official Regulatory Information
Medicinal product categories with documented interactions: Monoamine Oxidase Inhibitors (MAOIs); Central Nervous System (CNS) Depressants; Anticholinergic Drugs.
Timing-based interaction rules (if applicable): Must not be taken within 14 days of discontinuing therapy with Monoamine Oxidase Inhibitors (MAOIs).
Population-specific interaction notes (if applicable): Elderly patients are noted as being more susceptible to experiencing the neurological anticholinergic effects of the drug.

Official Interaction Statements:

  • Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated because MAOIs prolong and intensify the anticholinergic and general effects of Pheniramine maleate.
  • Concurrent administration with other CNS Depressants (including alcohol, opioid analgesics, hypnotics, sedatives, tranquilizers, anxiolytics, and antipsychotics) results in additive pharmacodynamic effects, formally described as increased CNS depression.
  • Co-administration with Anticholinergic Drugs (e.g., Atropine and related drugs) causes additive antimuscarinic action, increasing the documented risk of associated effects.

Connection to the overall interaction profile: The official labeling establishes a formal contraindication with MAOIs, which also mandates a specific 14-day timing rule. The profile also lists substances that cause additive effects due to shared pharmacologic properties. All documented statements are centered on label-based interaction outcomes and required regulatory restrictions.

Mechanism of Action

H1 Receptor Antagonism and Central Neuronal Modulation


Allervil exerts its primary pharmacodynamic effect by acting as a competitive antagonist at the histamine H1 receptor (H1R) on peripheral cells. The drug occupies these receptor binding sites, which suppresses the signaling cascade initiated by the endogenous mediator, histamine. This action directly affects pathways linked to increased vascular permeability and localized vasodilation, contributing to the limitation of histamine-mediated fluid leakage at the tissue level.

Additionally, Allervil possesses sufficient lipophilicity to cross the blood-brain barrier, engaging a secondary mechanism within the central nervous system (CNS). It acts as an inhibitor on specific voltage-gated sodium channels expressed by certain neurons. This inhibitory action modulates the flow of sodium ions, reducing the rate of neuronal signal transmission in central pathways that control arousal and psychomotor activity. This dual mechanism defines the drug's overall physiological profile.

Dosage and Administration Information

How to use Allervil

Allervil is administered via three distinct high-level routes based on the required effect: Oral (as tablets and syrup for systemic effect), Parenteral (Intravenous, Intramuscular, or Subcutaneous injection), and Topical Ophthalmic (eye drops for localized application). This versatility defines the administration method appropriate for each clinical scenario, with the parenteral forms typically reserved for specialized use settings.

Typical usage follows specific dosing and frequency patterns. For adults, oral use is generally two to three times daily, often starting at 12.5 mg or 25 mg per dose, while adhering to specified 24-hour maximums. The parenteral dose usually ranges from 10 mg to 22.75 mg per injection, with a strict maximum of 40 mg permitted within any 24-hour period. This injectable dose may be repeated after 8 to 12 hours if necessary. For topical use, the ophthalmic solution is applied up to four times daily.

Specific instructions are provided to support proper administration. Oral preparations are to be taken with or soon after food and should be swallowed whole. Intravenous administration must be performed slowly, over a period of at least one minute. The medicine is intended for short-term symptom management. Additionally, older adults and patients with hepatic or renal impairment should use the adult dose with caution, as these groups require careful consideration during use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Allervil

Evidence for Use in Allergic Rhinitis (Hay Fever and Nasal Symptoms)

This section will summarize the types of randomized controlled trials (RCTs) and systematic reviews that have studied Pheniramine maleate for nasal allergy symptoms and measured functional metrics like quality of life in adult and pediatric populations. Research explored how symptoms change over time in conditions characterized by fluctuating manifestations. Studies monitored symptom severity scores (like the Total Nasal Symptom Score) and the time it takes for a change in symptom reporting to be observed. Findings describe patterns observed in the studies over defined time intervals typically ranging from 14 to 30 days. However, some trials included Allervil as part of a combination product (e.g., with a decongestant), which means that research exploring the isolated action of Pheniramine maleate alone is limited.


Evidence for Use in Allergic Conjunctivitis (Ocular Symptoms)

Research for the topical formulation includes placebo-controlled RCTs often utilizing the allergen challenge model. These studies monitored specific acute ocular symptoms like itching, redness, and swelling. Assessments were structured to explore short-term symptom changes with follow-up periods measured in minutes after allergen exposure. Findings indicate that observed changes were measured only in the initial hours post-administration.


Evidence for Use in Urticaria and Pruritus (Hives and Itching)

The evidence foundation for managing cutaneous symptoms largely relies on regulatory monographs and literature summaries describing patterns consistent with the first-generation H1 antagonist class. Research explored patient-reported outcomes describing perceived discomfort by monitoring the evolution of pruritus (itching) and the presence of cutaneous swelling. This evidence contributes to the broader evidence landscape for these conditions.


Studies in Special Populations and Research Gaps

While Allervil was studied for use in adults, it was observed in some pediatric groups. However, the evidence supporting symptomatic management for children often relies on the application of adult data through regulatory extrapolation. Most efficacy trials lasted only 14 to 30 days. Consequently, long-term effects are not fully established. Furthermore, the inclusion of other active ingredients in many contemporary research scenarios limits the ability of the research to determine the exact symptomatic patterns observed for Pheniramine maleate alone.

Key Studies & References

  1. Label: EYE ALLERGY RELIEF - pheniramine maleate and naphazoline hydrochloride solution/ drops (DailyMed - NIH)
  2. Pheniramine - MotherToBaby (Fact Sheets on exposure in pregnancy and while breastfeeding)
  3. Rhinitis 2020: A practice parameter update (AAA&I/ACAAI Clinical Guideline)

Frequently Asked Questions (FAQ)

Common questions about Allervil (FAQ)


Q: Is Allervil a prescription drug or can I buy it over the counter?

Regulatory status can vary, but the active ingredient, Pheniramine maleate, is an established pharmaceutical agent. It is commonly available as an over-the-counter (OTC) ingredient, frequently used in combination with other components in cold and flu remedies. Prescription forms of the drug may also be available for specific uses or regions.


Q: Can I drive or operate machinery while taking Allervil?

Official product information cautions that Allervil may cause drowsiness, dizziness, or impaired coordination. Due to these effects, individuals should exercise caution and avoid driving or operating machinery until they understand the medication's full impact.


Q: Can Allervil affect the results of a standard allergy skin test?

Yes, regulatory science indicates that Allervil, as an antihistamine, works by blocking the body's natural histamine response. Official guidance recommends that the compound be discontinued for a specified period (often 3 to 7 days) prior to testing, as it can suppress the necessary positive reaction, leading to potentially inaccurate results.


Q: Does Allervil interact with common pain relievers like ibuprofen or acetaminophen?

Official product information generally indicates that no major interactions have been established between pheniramine and common pain relievers like ibuprofen or acetaminophen. However, patients are generally advised to be aware of all concurrent medications.


Q: Can Allervil be taken with a cold or flu medication?

Pheniramine is a common ingredient in over-the-counter cold and flu products, indicating it can be used in combination with some ingredients. Official warnings emphasize checking that cold or flu products do not contain another antihistamine or CNS depressant, which could lead to additive effects, such as increased drowsiness.


Q: Is Allervil associated with any risks of dependency or addiction?

Regulatory literature notes the potential for abuse (non-medical use) of Pheniramine. Studies have also noted the potential for users to develop tolerance to the drug's sedative effects over time.


Q: Are there any specific foods or drinks that should be avoided while using Allervil?

Official product warnings advise against the use of alcohol, as this can intensify the drug's effects on the central nervous system (CNS depression). There are no specific restrictions against common foods, and oral preparations are generally recommended to be taken with or soon after food.


Q: Does Allervil cause dry mouth or dry eyes?

Official safety documents list dry mouth (xerostomia) as a commonly reported adverse reaction. Due to the drug's anticholinergic properties, side effects such as dry eyes or temporary visual disturbances, like blurriness, have also been reported.


Q: Does Allervil cause weight gain or changes in appetite?

Official documentation concerning side effects notes that this drug can be associated with changes in the gastrointestinal system, including potential loss of appetite and constipation. Weight gain is not generally listed as a primary side effect in the regulatory information.


Q: Does Allervil affect sleep patterns or cause insomnia?

While the main central nervous system (CNS) effect is drowsiness (somnolence), official listings show that effects on the nervous system can be varied. Some individuals may experience the opposite reaction, with possible side effects including insomnia (difficulty sleeping) or general nervousness and agitation.


Q: How long does Allervil stay in the body after the last dose?

The amount of time the drug remains in the body is described by its terminal half-life, which is approximately 8 to 17 hours after administration.


Q: How long does the effect of one dose of Allervil typically last?

The therapeutic anti-allergic effect is commonly reported to last for approximately 4 to 6 hours. This duration aligns with the frequency with which the medication is sometimes prescribed (two to three times daily).


Q: What happens to Allervil in the body after it is taken?

After absorption, the active ingredient is broken down (metabolized) into other compounds. These substances are then primarily cleared from the body through the kidneys (renal excretion).


Q: Why is Allervil sometimes taken at night instead of during the day?

Regulatory information indicates that Allervil has a known sedative action, and drowsiness (somnolence) is the most frequently reported side effect. Taking the medicine at night is a practice often adopted to utilize the sedative effect, helping to limit daytime impairment.


Q: What are the common reasons people stop taking Allervil?

Official documents state this medication is formally designated for short-term symptom management. For this reason, many users stop taking it when their allergic symptoms resolve. Discontinuation may also occur because the drug's sedative properties lead to excessive drowsiness or tiredness.


Q: What if I experience unusual or rare side effects not commonly discussed?

Official regulatory systems, such as the FDA's MedWatch, are in place to allow for the reporting of any serious or unexpected reactions encountered during the use of a medicine.


Q: Can Allervil be used for non-allergy conditions, like itchiness for other reasons?

The established uses documented in regulatory sources are for allergic conditions, including the suppression of allergy-related itching (pruritus) and related skin conditions.


Q: Are there generic versions of Allervil available?

The active ingredient, Pheniramine maleate, is an established substance that has been available for an extended period. Because of this, the ingredient is widely available in many different generic drug preparations, in addition to branded products, and is often included in various combination cold remedies.


Q: What happens if I miss a scheduled dose of Allervil?

General guidance for medicines in this class suggests that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for your next scheduled dose, the common procedure is to skip the missed dose and resume your regular schedule.


Q: Are there any known interactions between Allervil and herbal supplements?

The product labeling does not typically list specific common herbal supplements that must be avoided. However, the official interaction warnings caution against combining Allervil with any substance—including herbal products—that may cause central nervous system (CNS) depression or have anticholinergic properties.


Q: What is the purpose of the black box warning (if any) associated with Allervil?

Pheniramine maleate does not have the FDA’s most prominent warning, known as a 'black box warning.' However, the drug class is subject to general regulatory cautions concerning serious side effects, such as the risk of severe hypersensitivity and respiratory depression in very young children.


Q: Can Allervil be taken if I am already taking blood pressure medication?

Official warnings recommend that the potential for interactions, such as QTc prolongation (an effect on the heart's electrical rhythm), be assessed when used alongside specific cardiovascular medicines.


Q: Why do official documents emphasize taking Allervil with a full glass of water?

While the product labeling specifies taking the oral forms with or soon after food, general pharmaceutical administration guidelines recommend swallowing oral tablets with a drink of water. This is advised to aid in proper ingestion and guarantee that the tablet is not caught in the throat.


Q: Is it necessary to take Allervil at the exact same time every day?

Patients commonly take the medication when they need it for symptom relief. While consistent timing can be helpful for regular use, strict adherence to the exact minute is not typically a regulatory requirement.

How should Allervil be stored and disposed of?

How to Store and Dispose of Allervil (Pheniramine Maleate)

The official labeling mandates specific storage conditions to maintain the stability of Allervil. The medicine must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions.

Mandatory Storage Requirements

Condition Requirement
Environment Protect from light and moisture.
Temperature Do not freeze and avoid excessive heat.
Packaging Store in the original container and keep it tightly closed.
Safety Keep out of the sight and reach of children.

Disposal

Unused or expired Allervil must be disposed of according to local regulations. The product must not be disposed of via wastewater (such as flushing down a toilet) and should preferably be returned through a pharmaceutical take-back system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allervil found in:

A-Z Index: